Literature DB >> 14985712

Notch regulation of lymphocyte development and function.

Freddy Radtke1, Anne Wilson, Stephane J C Mancini, H Robson MacDonald.   

Abstract

Notch proteins regulate a broad spectrum of cell fate decisions and differentiation processes during fetal and postnatal development. Mammals have four Notch receptors that bind five different ligands. The function of Notch signaling during lymphopoiesis and T cell neoplasia, based on gain-of-function and conditional loss-of-function approaches for the Notch1 receptor, indicates Notch1 is essential in T cell lineage commitment. Recent studies have addressed the involvement of other Notch receptors and ligands as well as their downstream targets, demonstrating additional functions of Notch signaling in embryonic hematopoiesis, intrathymic T cell development, B cell development and peripheral T cell function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985712     DOI: 10.1038/ni1045

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  160 in total

1.  Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development.

Authors:  Juan Xiong; Michael A Armato; Thomas M Yankee
Journal:  Int Immunol       Date:  2010-12-09       Impact factor: 4.823

2.  IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation.

Authors:  Yanping Yang; Hui Wang; Hui Yu; Beow Yong Yeap; Tingting Liang; Guanjun Wang; Tao Cheng; Yong-Guang Yang
Journal:  Blood       Date:  2011-08-11       Impact factor: 22.113

3.  HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes.

Authors:  Gladys W Wong; Gisele C Knowles; Tak W Mak; Adolfo A Ferrando; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

Review 4.  Decision checkpoints in the thymus.

Authors:  Andrea C Carpenter; Rémy Bosselut
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

5.  Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

Authors:  Bas J Wouters; Meritxell Alberich Jordà; Karen Keeshan; Irene Louwers; Claudia A J Erpelinck-Verschueren; Dennis Tielemans; Anton W Langerak; Yiping He; Yumi Yashiro-Ohtani; Pu Zhang; Christopher J Hetherington; Roel G W Verhaak; Peter J M Valk; Bob Löwenberg; Daniel G Tenen; Warren S Pear; Ruud Delwel
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

6.  Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.

Authors:  Ke Lan; Daniel A Kuppers; Erle S Robertson
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 7.  Regulation of acquired immune system by notch signaling.

Authors:  Yoshiaki Minato; Koji Yasutomo
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

8.  Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling.

Authors:  Tom N Taghon; Elizabeth-Sharon David; Juan Carlos Zúñiga-Pflücker; Ellen V Rothenberg
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

9.  Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction.

Authors:  Mika Kijima; Takeshi Yamaguchi; Chieko Ishifune; Yoichi Maekawa; Akemi Koyanagi; Hideo Yagita; Shigeru Chiba; Kenji Kishihara; Mitsuo Shimada; Koji Yasutomo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

10.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.